Pancrex V oral powder

Country: United Kingdom

Bahasa: Inggeris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Amylase; Lipase; Protease

Boleh didapati daripada:

Essential Pharma Ltd

Kod ATC:

A09AA02

INN (Nama Antarabangsa):

Amylase; Lipase; Protease

Dos:

30000unit ; 25000unit ; 1400unit

Borang farmaseutikal:

Powder for gastroenteral or oral liquid

Laluan pentadbiran:

Oral

Kelas:

No Controlled Drug Status

Jenis preskripsi:

Never Valid To Prescribe As A VMP

Ringkasan produk:

BNF: 01090400; GTIN: 5015001141022

Risalah maklumat

Tear here,
BUT DO NOT REMOVE
EAN CODE
EAN CODE
Batch no.:
Manuf. date:
Expiry date:
PanVPow-LPL-UK-1
PanVPow-LPL-UK-1
PanVPow-LPL-UK-1
P
P
CONTAINS LACTOSE. SEE LEAFLET FOR FURTHER INFORMATION
CONTAINS LACTOSE. SEE LEAFLET FOR FURTHER INFORMATION
IN THIS LEAFLET:
1.
What Pancrex V Powder is and what it is used for
2.
Before you take Pancrex V Powder
3.
How to take Pancrex V Powder
4.
Possible side effects
5.
How to store Pancrex V Powder
6.
Further information
1.
WHAT PANCREX V POWDER IS AND
WHAT IT IS USED FOR
The active ingredient in Pancrex V Powder is
PANCREATIN.
Pancreatin is a combination of enzymes normally produced
by the pancreas which help to digest protein, fat, starch and
sugars in the food that you eat.
Pancreatin is given to people who do not produce enough
enzymes to digest their food properly, in conditions such as
cystic fibrosis, persistent inflammation of the pancreas, and
when the pancreas has been removed. Pancrex V Powder
may also be used when the stomach has been removed, as an
aid to digestion.
The pancreatin in Pancrex V Powder is derived from
pancreases of pigs.
2.
BEFORE YOU TAKE PANCREX V POWDER
DO NOT TAKE PANCREX V POWDER IF YOU
•
are
ALLERGIC
(hypersensitive) to
PANCREATIN
There are no known diseases that may prevent you from
taking Pancrex V Powder.
TAKING OTHER MEDICINES
Pancrex V Powder is not known to interfere with any other medicines
that you may be taking. However, if you are
prescribed another medicine, inform the doctor you are
taking Pancrex V Powder.
PREGNANCY AND BREAST-FEEDING
If you are pregnant, thinking of becoming pregnant or breast-feeding,
discuss this with your doctor before taking your
medicine as dose adjustments may be necessary.
Ask your doctor or pharmacist for advice before taking any medicine.
DRIVING AND USING MACHINES
Pancrex V Powder does not interfere with your ability to drive
or operate machinery.
IMPORTANT INFORMATION ABOUT SOME OF THE INGREDIENTS OF
PANCREX V POWDER
•
LACTOSE
If you have been told by your doctor that you have an
intolerance to

Ciri produk

OBJECT 1
PANCREX V POWDER
Summary of Product Characteristics Updated 10-Feb-2017 | Essential
Pharmaceuticals Ltd
1. Name of the medicinal product
Pancrex V Powder
2. Qualitative and quantitative composition
Pancreatin BP to provide enzymatic activity per gram not less than:
Free protease
1400 BP units
Lipase
25000 BP units
Amylase
30000 BP units
3. Pharmaceutical form
Powder.
4. Clinical particulars
4.1 Therapeutic indications
Pancrex is used to compensate for reduced intestinal enzyme activity
in pancreatic deficiency states.
It is indicated for the treatment of fibrocystic disease of the
pancreas (cystic fibrosis), chronic pancreatitis
and pancreatic steatorrhoea following pancreatectomy. It may also be
indicated following gastrectomy as
an aid to digestion.
4.2 Posology and method of administration
Posology
Dosage should be adjusted according to the needs of the individual
patient and the amount and type of
food consumed. The following dosage ranges provide a suitable basis
for adjustment.
Adults, the Elderly, and Children
0.5 g - 2 g swallowed dry or mixed with a little water or milk before
each snack or meal.
New-born infants
0.25 g - 0.5 g with each feed.
Method of administration
(1) Oral
(2) Pancrex V Powder may be administered via a nasogastric tube or a
gastrostomy tube. Refer to relevant
local and national official guidelines (see section 4.4).
4.3 Contraindications
Hypersensitivity to the active ingredient (porcine pancreatin) or to
any of the excipients listed in section
6.1.
4.4 Special warnings and precautions for use
It is possible that some irritation of the skin of the mouth may occur
if the powder is retained in the
mouth. Irritation of the anus may also occur. A barrier cream may
prevent this local irritation.
Allergic/asthmatic reactions have occasionally occurred on handling
the powder.
Patients with rare hereditary problems of galactose intolerance, the
Lapp lactose deficiency or glucose-
galactose malabsorption should not take this medicine.
If the powder is mixed with liquids or feeds the